A higher than 85% selective knockdown of BRD4 was reported using concentrations of dBET1 as low as 100 nM in human AML cell line (MV4; 11) with a near complete knockdown 2 h after administration (Winter et al., 2015). The gene discussed is BRD4; the disease is acute myeloid leukemia.